Darp101 (@DarpResearch) profile picture

Stock investor, inventor and rusty geologist.

Joined June 2022
Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)Photo by Darp101 (@DarpResearch)
The Mining Report did new interview with Mark youtube.com/watch?v=XIZoWL1t… Today Cerrado $CRDOF is about the only gold miner that is up, mkt loves the deal and the results. Josh is investor that does these for free and asks hard questions. BTW I do love the deal and the Q. Mark is talking $500 million a year cashflow when all mines are up. Q AISC is impressively low.
1
3
5
508
AI fought me (Grok) but finally it answered my question is this is the worst 2-week midterm election reaction? After 8 asks this. BTW this is not about politics, this crash in stocks, oil, gold, copper, silver is so severe wante dto know how it compared. Not sure what this means but is it by 2 to 1 the worst reaction for all 4 combined, most years were positive so an extreme outlier. Approximate ~2-week post-midterm returnsYear Election Date S&P 500 Oil (WTI/USO proxy) Gold. Silver 2022 Nov 8 (published +5.7% in first week) 2018 Nov 6 (published −2.5%) 2014 Nov 4 (published −0.6%) 2010 Nov 2 (published +4.9%) And so forth we are down about 9.5% avg on all 4 prices in 2026 , so only one other year in 50 years was half as bad rest most positive or even. This time is different for whatever reasons
1
142
FDA Breakthrough Therapy Designation — Market Approval Rate 72%, 13% still under review, 15% Fail, bodes well for $NGEN NervGen NVG-291. Plus, Faster Approvals NervGen's NVG-291 peptide just got Breakthrough status for their SCI paralysis healing drug. nervgen.com/nervgen-announce… Here is a CBS TV report on it, showing fantastic benefit, youtu.be/Ynxu-hyCLxg About 72% of drugs granted the FDA’s Breakthrough Therapy designation between 2013 and 2022 ultimately received market approval BioSpace+1 Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report - BioSpace biospace.com/fda/nearly-thre… Latest data A 2025 Jefferies report, based on FDA data and analysis from Friends of Cancer Research and Biomedtracker, found that 223 of 599 breakthrough therapy–designated drugs from 2013–2022 were approved, 13% were still pending decisions, and the remainder failed during development BioSpace+1. This equates to roughly 72% approval rate for the period studied. Why the Approval Rate Is High Breakthrough Therapy Designation is reserved for drugs that: Treat serious or life‑threatening conditions. Show preliminary clinical evidence of substantial improvement over existing therapies. Because the FDA only grants BTD when early data already looks strong, the pool of candidates is pre‑selected for promise, which naturally raises the approval rate. Analysts quoted in the results note that this may reflect both: FDA’s ability to identify strong candidates early, and Potential confirmation bias, where designated drugs receive more attention and support 2 This is encouraging for those that need the drug and for the company's future sales. Drugs with Breakthrough Therapy Designation typically reach approval months to years faster than similar drugs without it, mainly because the designation accelerates development and often leads to Priority Review, which shortens FDA’s review goal to 6 months instead of 10. What Breakthrough Therapy Designation actually speeds Breakthrough Therapy designation is designed to expedite development, not just review. FDA states that BTD provides: All Fast Track features (more frequent communication, rolling review) 1 Intensive guidance beginning as early as Phase 1 1 Senior‑manager involvement to resolve issues quickly 1 1 Source This means clinical trial design, endpoint selection, and evidence generation are optimized early, reducing the time it takes to assemble an approvable application. How this compares to drugs without BTD Drugs without Breakthrough Therapy designation proceed through standard development timelines, with fewer FDA interactions and no special guidance. They may still receive Priority Review, but they do not benefit from the accelerated development-phase collaboration that BTD confers. The only explicit review‑time difference: Priority Review FDA’s Priority Review program—often granted to BTD drugs—sets a 6‑month review goal, compared with the 10‑month standard review goal Food and Drug Administration (.gov)+1 . BTD drugs frequently qualify for Priority Review, because the same evidence that supports BTD (substantial improvement over existing therapy) often meets Priority Review criteria. Non‑BTD drugs may or may not receive Priority Review, depending on their evidence. Thus, the review‑phase acceleration is clear and quantifiable: 6 months (Priority Review) vs. 10 months (standard review). Why BTD drugs often reach approval faster overall Even though FDA does not publish a single “average approval time” for BTD drugs, several mechanisms shorten the total timeline: Earlier, more efficient trial designs reduce development time. Rolling review allows FDA to evaluate sections of the application as they are completed 1 . Priority Review eligibility shortens the final review clock. Senior‑level FDA involvement helps resolve scientific and regulatory issues quickly
3
3
26
1,213
Finally NervGen $NGEN gets a helping hand from FDA NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury - NervGen PR Thanks!! nervgen.com/nervgen-announce… I have been encouraging people to get local TV station patient videos of people that have been greatly healed via NVG-291 to RFK, maybe one of you did that. Here is CBS video of man that regained the ability to walk with the drug. Experimental drug could provide hope for people with spinal cord injuries youtu.be/Ynxu-hyCLxg
2
1
31
1,367
The news for the trading halt is out just now. $AWJ Auric it is out ASX:AWJ - Acquisition of Iron Maiden Gold Project auricmining.com.au/announcem… and ASX:AWJ - Proposed issue of securities - AWJ auricmining.com.au/announcem… I just read it, barely touches their cash pile and tiny stock issuance, and lots of high grade cores. Looks good.
1
294
Big news for Auric $AWJ.ax, halted it hints an acquisition and a raise. Prior moves by them have been good hope it is another good move. auricmining.com.au/announcem…
1
202
Release Date: 10/11/26 11:59 Summary: Acquisition of Iron Maiden Gold Project Price Sensitive: Yes The announcement content will be available in 18 minutes at 12:19
60
About an hour ago, Josh at The Mining Report, a fairly major YouTube mining investment site, at my suggestion, looked at $AWJ.ax Auric. He could not believe what he found. Comments like "they must have raised money; did they sell something?" He thinks our numbers are impossible from operations, but that is where the money came from. We should get a lot of eyes on Auric from this; the audience is mainly USA, but this show was on ASX stocks. Queued to Auric section. Josh is one of the very best mining analysts out there. youtu.be/eCEnD-_gKpQ?t=3594 It will take some time for the USA crowd to buy but they will, I bet Josh will buy himself. He does not charge for these videos and often invests in the ones he likes. He said Auric looks so good that he will do a special show just on them. BTW, how they got the $38 million AUD roughly was by investing $1.5 million in a baby pit in West Australia getting about $15 million cash out of it then doing another baby pit and ending up with about $38 million cash, an amazing compounding via operations. It is discussed here Auric Mining Limited AWJ(ASX) - ASX Share Price & News | HotCopper Forum This video explains how they did it and what is next. They bought a mill and will greatly reduce their milling costs with it. youtu.be/vHuP3xUIRDg Cheers
2
2
557
Auric Mining Limited (ASX:AWJ) - Ann: Pause in Trading, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum big news halted
53
Brand new 1+ hour video interview of Ravi of $GGGOF Golconda Gold by Josh of The Mining Report. Still watching; excellent. It shows what a smart financial mind Ravi has. youtu.be/tyfbr9kXMeQ The gold miner has so much gold they are not drilling, as it would take so long to get through what they already have mapped out. JMHO, they could have in the neighborhood of 10 million oz before they run out; it has already operated for 150 years. That is Galaxy in S. Africa. They also have Summit in New Mexico, a Silver/gold mine they just restarted. They plan to spin out Summit as new stock. I like the plan. BTW Josh is one of the best interviewers out there, and he does not charge; he invests in many of the stocks and has $GGGOF.
1
1
3
1,057
Election Day. There is something that am suprised is not being talked about now (was a year ago), which is the huge Republican registration gain over the DNC. So asked Grok Q. How often is this big a gain in one party in registration after a presidential victory been followed by that party then losing control of the House or Senate in the midterms? A. Bottom line: There is no clear modern example of a registration gain “this big” (hundreds of thousands to a million-plus net relative improvement concentrated after a presidential victory) for the winning presidential party, followed by that party then losing House or Senate control in the midterm. The dominant historical force is the midterm penalty: the president’s party almost always loses seats (and often control) in the House, driven by approval ratings, turnout differentials, and the national environment. Registration trends more often reflect longer-term sorting and can be overridden by those factors. The recent post-2024 relative GOP registration strength is larger than the modest 2016–2018 shift and more comparable in scale to multi-year trends that have not prevented White House-party losses when midterm conditions were unfavorable. Rarely—essentially never in the modern era with a registration shift of the recent post-2024 scale, followed by the gaining party losing House or Senate control in the subsequent midterm.Party registration is tracked in only about 30 states, and consistent short-term (roughly 1–2 year post-presidential) national aggregates of large net shifts are limited. The recent relative Republican improvement (Democrats net losses approaching or exceeding 1 million in tracked states from late 2024 onward, building on larger multi-year declines) stands out in size compared with prior cycles. Midterms are dominated by the presidential party’s performance, not registration. IF YOU ARE INTERESTED THIS IS THE REST OF ANSWER: Historical midterm pattern (context)Since 1946, the president’s party has lost House seats in 18 of 20 midterms (average loss around 26 seats). House control has flipped several times in midterms (e.g., 1994, 2006, 2010, 2018, 2022). Senate losses for the president’s party are also common but less consistent, and control flips less often. Only twice since 1946 has the president’s party gained House seats (1998 under Clinton; 2002 under George W. Bush). Gains in both chambers in the same midterm are even rarer (2002 is the standout).Cases involving registration trends after a presidential winAfter 2008 (Obama/Democrats win presidency): Democrats saw strong registration surges tied to the presidential campaign (e.g., large gains in states like Florida). In the 2010 midterm, Democrats lost control of the House (net loss of 63 seats) and seats in the Senate. This is the closest parallel—the winning presidential party had registration momentum but still lost the House amid a classic midterm backlash. The concentrated post-election registration surge into the midterm period itself was not on the recent scale. After 2016 (Trump/Republicans win presidency): Net GOP registration shift across tracked states from 2016–2018 was modest (around 100,000). In some states (e.g., Pennsylvania), Democrats improved their edge. Republicans lost the House in 2018 (net loss of 41 seats) while gaining in the Senate. The registration gain was far smaller than recent figures, and the White House party still lost House control. After 2020 (Biden/Democrats win presidency): Republicans made substantial registration gains from 2020–2024 across nearly all party-registration states (a multi-year net swing on the order of several million relative to Democrats, per analyses such as the New York Times). In the 2022 midterm, Republicans (the out-party) gained the House. Democrats (the White House party, which had lost registration ground) lost the House while holding the Senate. Registration direction aligned with the seat outcome for the gaining party. Other cycles (e.g., after 2000, 2004, 2012): Available registration data shows more gradual shifts or independent growth rather than sudden large post-victory partisan registration surges of the recent magnitude. Outcomes followed the usual midterm penalty on the president’s party more than any registration signal.
229
It is a fairly well-written report, $MMTMF , $MMY.v Monument Annual. ceo.ca/content/sedar/MMY-202… The #1 one thing they push in it is that the stock has gone up in this 12-month period ending in June. Which is true. What they did not mention is that the stock is hyper-undervalued compared to the stock market and sector. That is a double-edged sword, good for newcomers, bad for existing shareholders. I did not see mention of any significant decision in FY2026, nor a deadline for any decisions in the future. Compare that to, say $CRDOF Cerrado or solana:GNhGFeK5rr6WWpsGC2TdorJwh7QwAMy9RuenSRWbjZrY: lots of decisions, lots of upcoming events. So MMY stands out as a super static company. The positive on MMY, outside of the absurdly low valuation, is it is a low AISC mine. That they have done a good job on. With them loaded to the gills with cash, why has mine life not been addressed sooner? And with valuations 1/2 as good as the current one, I have seen heavy insider buying commonly. They are net sellers, very odd. Then the elephant in the room: with easy, safe, and instant 95% ROI on EV via just buying back stock, why are they not doing that? If you look at the last year, Oct30 to Oct 30, $MMY.v is down 42%, GDXJ is down 16% and CERT Cerrado is up 27%. So, in the last year it is actually lagging. a lot. Cheers Note is you have or will get Monument stock and want to see buyback happen send your share counts to [email protected] a secure email. Thanks
128
There is a secure email now just for the $MMTMF $MMY.V Monument Mining buyback project. Later I will add a Signal group so people can chat without others seeing their phone numbers. The email is [email protected] It is up and working, very secure, just tested that this email works. This is the std format for buyback project Handle and contact point as in Geodan at CEO.CA, Shares (me) 440,000. You can add additional info, even suggestions if you wish, but this will be enough for me to tally. I am involved with a software development project, so I will be very busy meeting on that this week, in case you do not hear from me for a while. Thanks everyone for your help. We have 11 million shares so far, but more are coming in as soon as a secure email address is created for some people that wanted that first. Cheers For background on why this is a good idea. seekingalpha.com/article/495… And Wow, this one impresses even me. IRR on EV is 95% as is. To Grok: The IRR I think is on mkt cap what about if on EV, and what if on EV if they sell Murchison for $50 million, or for $100 million? On an enterprise-value basis the yield (and therefore the simple IRR of a buyback) is much higher. Selling Murchison makes it higher still. Current baseline (USD) Market cap ≈ $184 million Cash ≈ $110 million, Current EV ≈ $74 million Ongoing free-cash-flow / earnings power ≈ $65–70 million Basis Yield / approximate IRR Calculation Market cap ~38% $70M ÷ $184M Current EV ~95% $70M ÷ $74M The ~38% figure used earlier is the yield on market cap. On EV the same cash flows are being bought against a much smaller residual value, so the theoretical yield jumps to roughly 90–100%. If Murchison is sold A sale converts the Murchison asset into cash, which reduces enterprise value dollar-for-dollar (market cap held constant for the residual calculation). Murchison sale price New residual EV Yield on residual EV Notes $50 million ~$24 million ~290% IRR $70M ÷ $24M $100 million ~–$26 million Negative residual EV Market assigns negative value to Selinsing’s earnings after cash + Murchison proceeds At a $50 million sale, the residual EV left for Selinsing is only ~$24 million against ~$70 million of annual free cash flow — an extreme yield. At a $100 million sale, residual EV turns negative. The market would be implying that Selinsing’s ongoing earnings power has less than zero value once Murchison cash is recognized. Bottom line for the buyback The IRR of buying back stock at the current price is already very high on a market-cap basis (~35–40%). On an EV basis it is dramatically higher (~95%). Any meaningful sale of Murchison further increases the residual yield on the operating business and makes a buyback at today’s prices even more accretive to remaining shareholders. So IRR is 95% on EV as is, and infinity, incalculable, if Murchison is sold, on buybacks. No need to sell Murchison; just to buybacks- EPS will skyrocket, which means the stock price will skyrocket. Cheers
1
1
591
Here is another way to look at $MMTMF Monument Mining buybacks. Buybacks = IRR on EV is 95% as is. If they firesale Murchison then it is ~290% IRR To Grok: The IRR I think is on mkt cap what about if on EV, and what if on EV if they sell Murchison for $50 million, or for $100 million? On an enterprise-value basis the yield (and therefore the simple IRR of a buyback) is much higher. Selling Murchison makes it higher still. Current baseline ($USD) Market cap ≈ $184 million Cash ≈ $110 million, Current EV ≈ $74 million Ongoing free-cash-flow / earnings power ≈ $65–70 million Basis Yield / approximate IRR Calculation Market cap ~38% $70M ÷ $184M Current EV ~95% $70M ÷ $74M The ~38% figure used earlier is the yield on market cap. On EV the same cash flows are being bought against a much smaller residual value, so the theoretical yield jumps to roughly 90–100%. If Murchison is sold a sale converts the Murchison asset into cash, which reduces enterprise value dollar-for-dollar (market cap held constant for the residual calculation). Murchison sale price New residual EV Yield on residual EV Notes: $50 million ~$24 million ~290% IRR $70M ÷ $24M $100 million ~–$26 million Negative residual EV Market assigns negative value to Selinsing’s earnings after cash + Murchison proceeds At a $50 million sale, the residual EV left for Selinsing is only ~$24 million against ~$70 million of annual free cash flow — an extreme yield. At a $100 million sale, residual EV turns negative. The market would be implying that Selinsing’s ongoing earnings power has less than zero value once Murchison cash is recognized. Bottom line for the buyback The IRR of buying back stock at the current price is already very high on a market-cap basis (~35–40%). On an EV basis it is dramatically higher (~95%). Any meaningful sale of Murchison further increases the residual yield on the operating business and makes a buyback at today’s prices even more accretive to remaining shareholders. So IRR is 95% on EV as is, and infinity, incalculable, if Murchison is sold at a reasonable value, and 290% IRR if Murchison sold very cheap when buybacks are done. No need to sell Murchison; just do buybacks- EPS will skyrocket, which means the stock price will skyrocket. Cheers
1
419
Looked at the valuation of Monument Mining $MMTMF some more, and the below indicates it is less than free. The Seeking Alpha article by hedge fund Cedar Creek pointed out that "Since current cash is likely in excess of $125 million, Monument trades at a ridiculous valuation of less than one times earnings net of cash.: Today, in USD $191 million market cap, -$125 million cash = $66 million EV, just counting cash; add in from Cedar Partners article "In addition, Odyssey Gold, another smaller junior miner, who purchased Monument's Tuckanarra assets in Australia a few years ago is reportedly nearing production that could result in $20 to 30 million in aggregate earnings for Monument over the next few years. " seekingalpha.com/article/495… Then the assets they have at Murchison, AI says are worth $140ish million usd. A mining company CEO who has looked in that general area says that they could sell it for $100 million. So call it $10 million on Tuckanarra NPV and $100 million for Murchison, so $66 million EV just on cash, then - $ 110 million = negative real EV of $44 million, so PE ratio could be seen as below Zero, so it can be seen as not just less than 1 PE, it can be seen as less than zero. If so, this is one of the most spectacular values ever in the stock market. I put this through AI and it said the numbers and ratios are right if Murchison can be sold for $100 million. "The calculation itself $66M EV (on cash) − $110M (your $10M + $100M) = negative ~$44M is arithmetically correct with those inputs. What this actually says in a sum-of-the-parts sense is that the market is assigning zero or negative value to the producing Selinsing mine (which just generated ~$69M of net income) after giving credit for cash + the estimated Australian assets. That is an extremely cheap SOTP outcome if the asset values prove out."
1
199